Welcome to our dedicated page for KAYA HOLDINGS news (Ticker: $KAYS), a resource for investors and traders seeking the latest updates and insights on KAYA HOLDINGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KAYA HOLDINGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KAYA HOLDINGS's position in the market.
Kaya Holdings, Inc. (KAYS) has been awarded a license to operate a Psilocybin Service Center in Oregon, becoming the first state in the US to allow Psilocybin administration in a legal setting. Through its subsidiary Fifth Dimension Therapeutics, KAYS will launch The Sacred Mushroom, a psychedelic treatment facility offering innovative experiences. The facility is set to open within the next thirty days in downtown Portland, covering 11,000 square feet. Psilocybin, a compound in magic mushrooms, has shown promise in treating various mental health conditions. KAYS aims to be a leader in psychedelic care delivery, offering a unique guest experience. The US behavioral health market is growing, creating opportunities for companies like KAYS to provide alternative therapies.
